What is Insmed's financing cash flow?

Insmed (INSM) reported financing cash flow of $29.51M in Q1 2026.

How has Insmed's financing cash flow changed year-over-year?

Insmed's financing cash flow increased by 1.8% year-over-year, from $29M to $29.51M.

What is the long-term trend for Insmed's financing cash flow?

Over 4 years (2021 to 2025), Insmed's financing cash flow has grown at a 11.7% compound annual growth rate (CAGR), from $612.55M to $954.07M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Insmed INSM Financing Cash Flow

Financing Cash Flow at other companies

Sarepta Therapeutics, Inc.SRPT

$241K-98.1%

United TherapeuticsUTHR

-$1.48B-1,483%

Solid Biosciences Inc.SLDB

$239.03M+26.0%

ANI PharmaceuticalsANIP

-$21.62M-118%

Regeneron PharmaceuticalsREGN

-$802.2M+26.3%

SavaraSVRA

-$195K-108%

Other financials

Income statement

See full

Revenue$306.0M+230%

Gross profit$258.5M+261%

Operating income-$153.3M+38.2%

Net income-$163.6M+36.3%

EPS (diluted)-$0.76+46.5%

Balance sheet

See full

Cash & equivalents$582.2M+44.4%

Total debt$580.3M-49.2%

Total equity$704.9M+611%

Total assets$2.1B+15.2%

Cash flow

See full

Operating cash flow-$222.7M+15.0%

CapEx$3.5M-65.4%

Free cash flow-$226.2M+16.9%

Valuation

See full

Market cap$23.11B+17.6%

Enterprise value$23.11B+22.0%

P/S28.2×-21.1×

Profitability

See full

Gross margin81.8%+5.3pp

Operating margin-140.6%-43.9pp

Net margin-144.4%-45.3pp

FCF margin-112.5%-35.3pp

Returns & leverage

See full

Return on equity-294.5%—

Debt / equity0.8×-10.7×

Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insmed's financing cash flow?: Insmed (INSM) reported financing cash flow of $29.51M in Q1 2026.
How has Insmed's financing cash flow changed year-over-year?: Insmed's financing cash flow increased by 1.8% year-over-year, from $29M to $29.51M.
What is the long-term trend for Insmed's financing cash flow?: Over 4 years (2021 to 2025), Insmed's financing cash flow has grown at a 11.7% compound annual growth rate (CAGR), from $612.55M to $954.07M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.